First Time Loading...

Sierra Oncology Inc
NASDAQ:SRRA

Watchlist Manager
Sierra Oncology Inc Logo
Sierra Oncology Inc
NASDAQ:SRRA
Watchlist
Price: 54.99 USD Market Closed
Updated: May 17, 2024

Sierra Oncology Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sierra Oncology Inc
Interest Income Expense Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Sierra Oncology Inc
NASDAQ:SRRA
Interest Income Expense
-$100k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Interest Income Expense
$18.5m
CAGR 3-Years
36%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Interest Income Expense
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Interest Income Expense
$4.1m
CAGR 3-Years
131%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Interest Income Expense
$13.7m
CAGR 3-Years
157%
CAGR 5-Years
N/A
CAGR 10-Years
34%
Spectral Medical Inc
TSX:EDT
Interest Income Expense
-CA$3.2m
CAGR 3-Years
-373%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sierra Oncology Inc's Interest Income Expense?
Interest Income Expense
-100k USD

Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's Interest Income Expense amounts to -100k USD.